![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 40, 29501-29512, October 6, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Suppresses Integrin Activation*
1
12
13


4
From the
Medical Research Council Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4SA, Scotland, United Kingdom and the
Department of Medicine, University of California, San Diego, La Jolla, California 92093-0726
Phospholipase C
(PLC
) is a newly described effector of the small GTP-binding protein H-Ras. Utilizing H-Ras effector mutants, we show that mutants H-Ras(G12V/E37G) and H-Ras(G12V/D38N) suppressed integrin activation in an ERK-independent manner. H-Ras(G12V/D38N) specifically activated the PLC
effector pathway and suppressed integrin activation. Inhibition of PLC
activation with a kinase-dead PLC
mutant prevented H-Ras(G12V/D38N) from suppressing integrin activation, and low level expression of H-Ras(G12V/D38N) could synergize with wild-type PLC
to suppress integrins. In addition, knockdown of endogenous PLC
with small interfering RNA blocked H-Ras(G12V/D38N)-mediated integrin suppression. Suppressing integrin function with the H-Ras(G12V/D38N) mutant reduced cell adhesion to von Willebrand factor and fibronectin; this reduction in cell adhesion was blocked by coexpression of the kinase-dead PLC
mutant. These results show that H-Ras suppresses integrin affinity via independent Raf and PLC
signaling pathways and demonstrate a new physiological function for PLC
in the regulation of integrin activation.
Received for publication, December 19, 2005 , and in revised form, August 7, 2006.
* This work was supported in part by a Scottish Health Research and Education Trust project grant (to Y. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 These authors contributed equally to this work.
2 Supported by a British Heart Foundation junior fellowship.
3 Supported by a Medical Research Council Clinical Research Training Fellowship.
4 Supported by a Wellcome Trust leave fellowship. To whom correspondence should be addressed. Tel.: 44-131-242-6550; Fax: 44-131-242-6578; E-mail: t.sethi{at}ed.ac.uk.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. H. Ulfman, V. M. Kamp, C. W. van Aalst, L. P. Verhagen, M. E. Sanders, K. A. Reedquist, M. Buitenhuis, and L. Koenderman Homeostatic Intracellular-Free Ca2+ Is Permissive for Rap1-Mediated Constitutive Activation of {alpha}4 Integrins on Eosinophils J. Immunol., April 15, 2008; 180(8): 5512 - 5519. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Hodkinson, Paul. A. Elliott, Y. Lad, B. J. McHugh, A. C. MacKinnon, C. Haslett, and T. Sethi Mammalian NOTCH-1 Activates beta1 Integrins via the Small GTPase R-Ras J. Biol. Chem., September 28, 2007; 282(39): 28991 - 29001. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |